Mutation Identification: Detecting genetic changes that may affect cancer cell growth Guiding Treatment Options: Determining if the patient is eligible for targeted therapies such as signal inhibitors Assessing Treatment Response: Understanding how mutations may influence the patient’s response to medications Monitoring Disease Progression: Providing insights into how the tumor develops and its aggressiveness Risk Assessment: Helping physicians evaluate the likelihood of recurrent cancer or further complications

Patients with Colon Cancer: To identify mutations that may affect the response to chemotherapy and targeted therapy Patients with Head and Neck Cancer: To monitor genetic mutations that may guide treatment choices Individuals with a Family History of Cancer: To assess genetic risks and support early treatment decisions Patients with Solid Tumors: Such as malignant tumors, where mutations can provide important insights into disease progression Patients Receiving Targeted Therapy: To monitor response and guide treatment options based on genetic findings

Cancer Diagnosis: Such as colon cancer or head and neck cancer, especially when determining treatment options Chemotherapy Failure: If the patient does not respond to the prescribed treatment, prompting evaluation of genetic mutations Cancer Recurrence: Recurrent or advanced cancer cases where mutations may help identify the cause Worsening Symptoms: New or worsening symptoms that may indicate disease progression Family History of Cancer: A strong family history of cancer may warrant testing to assess genetic risks

What is the purpose of NRAS testing? It is used to detect genetic mutations in the NRAS gene to guide treatment options in cancer cases. How is the test performed? A sample of cancer tissue or blood is taken and then analyzed in the laboratory. Is fasting required before the test? Fasting is usually not required, but it is recommended to consult your doctor regarding any special precautions. What are the normal values for this test? There are no "normal values" in the traditional sense; the focus is on identifying mutations. What can affect the test results? The use of certain medications, sample type, and collection timing can affect the results. What do positive NRAS mutation results mean? Positive results indicate the presence of mutations that may affect treatment options and patient response. Can this test be needed more than once? Yes, especially if the patient’s condition changes or if monitoring disease progression is necessary. When will the results be available? Results are usually available within days to weeks, depending on the laboratory.

Presence of Mutations: Indicates that there are genetic changes that may affect the tumor's response to treatment. Absence of Mutations: Indicates that the NRAS gene does not contain known mutations, which may suggest a different response to treatment.

NRAS Gene Mutation Test | Lahalak Medical Platform

An advanced genetic test to detect NRAS gene mutations, helping doctors determine the most suitable targeted therapy for cancer cases and ensuring a better, more precise treatment response.

Prices starts from: 798.84 SAR

Scientific name: NRAS Gene Mutation Test

The NRAS test is an important genetic test used to detect mutations in the NRAS gene, which plays a vital role in regulating cell growth and division. This test is particularly used in evaluating cancer cases, such as colorectal cancer and head and neck cancer. The results of the NRAS test help doctors determine whether the patient will respond to...

NRAS Gene Mutation Test - Cancer Genetic Mutation Test

Service type Genetic test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 798.84 SAR

Included Services

NRAS Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Mutation Identification: Detecting genetic changes that may affect cancer cell growth
Guiding Treatment Options: Determining if the patient is eligible for targeted therapies such as signal inhibitors
Assessing Treatment Response: Understanding how mutations may influence the patient’s response to medications
Monitoring Disease Progression: Providing insights into how the tumor develops and its aggressiveness
Risk Assessment: Helping physicians evaluate the likelihood of recurrent cancer or further complications

Recommended groups

Patients with Colon Cancer: To identify mutations that may affect the response to chemotherapy and targeted therapy
Patients with Head and Neck Cancer: To monitor genetic mutations that may guide treatment choices
Individuals with a Family History of Cancer: To assess genetic risks and support early treatment decisions
Patients with Solid Tumors: Such as malignant tumors, where mutations can provide important insights into disease progression
Patients Receiving Targeted Therapy: To monitor response and guide treatment options based on genetic findings

Symptoms indicative

Cancer Diagnosis: Such as colon cancer or head and neck cancer, especially when determining treatment options
Chemotherapy Failure: If the patient does not respond to the prescribed treatment, prompting evaluation of genetic mutations
Cancer Recurrence: Recurrent or advanced cancer cases where mutations may help identify the cause
Worsening Symptoms: New or worsening symptoms that may indicate disease progression
Family History of Cancer: A strong family history of cancer may warrant testing to assess genetic risks

FAQs

What is the purpose of NRAS testing? It is used to detect genetic mutations in the NRAS gene to guide treatment options in cancer cases.
How is the test performed? A sample of cancer tissue or blood is taken and then analyzed in the laboratory.
Is fasting required before the test? Fasting is usually not required, but it is recommended to consult your doctor regarding any special precautions.
What are the normal values for this test? There are no "normal values" in the traditional sense; the focus is on identifying mutations.
What can affect the test results? The use of certain medications, sample type, and collection timing can affect the results.
What do positive NRAS mutation results mean? Positive results indicate the presence of mutations that may affect treatment options and patient response.

Normal Levels

Presence of Mutations: Indicates that there are genetic changes that may affect the tumor's response to treatment.
Absence of Mutations: Indicates that the NRAS gene does not contain known mutations, which may suggest a different response to treatment.